Efgartigimod alfa
Efgartigimod alfa (ARGX-113) is a neonatal Fc receptor (FcRn) blocker. Efgartigimod alfa is an anti FcRn monoclonal immunoglobulin G (IgG1) Fc fragment. Efgartigimod alfa can be used for the research of myasthenia gravis[1].
Product Specifications
CAS Number
1821402-21-4
Product Name Alternative
ARGX-113
UNSPSC
12352203
Target
Fc Receptor (FcR)
Related Pathways
Immunology/Inflammation
Field of Research
Inflammation/Immunology
Purity
99.50
Solubility
10 mM in DMSO
Smiles
[Efgartigimodalfa]
Molecular Weight
(51.28 kDa)
References & Citations
[1]Heo YA. Efgartigimod: First Approval. Drugs. 2022 Feb;82 (3) :341-348.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
